USAF EK-1597 en es it fr

USAF EK-1597 Brand names, USAF EK-1597 Analogs

USAF EK-1597 Brand Names Mixture

  • No information avaliable

USAF EK-1597 Chemical_Formula


USAF EK-1597 RX_link

USAF EK-1597 fda sheet

USAF EK-1597 msds (material safety sheet)


USAF EK-1597 Synthesis Reference

No information avaliable

USAF EK-1597 Molecular Weight

46.0684 g/mol

USAF EK-1597 Melting Point

-114.1 oC

USAF EK-1597 H2O Solubility

Miscible in water

USAF EK-1597 State


USAF EK-1597 LogP


USAF EK-1597 Dosage Forms


USAF EK-1597 Indication

For therapeutic neurolysis of nerves or ganglia for the relief of intractable chronic pain in such conditions as inoperable cancer and trigeminal neuralgia (tic douloureux), in patients for whom neurosurgical procedures are contraindicated.

USAF EK-1597 Pharmacology

Alcohol produces injury to cells by dehydration and precipitation of the cytoplasm or protoplasm. This accounts for its bacteriocidal and antifungal action. When alcohol is injected in close proximity to nerve tissues, it produces neuritis and nerve degeneration (neurolysis). Ninety to 98% of ethanol that enters the body is completely oxidized. Ethanol is also used as a cosolvent to dissolve many insoluble drugs and to serve as a mild sedative in some medicinal formulations.

USAF EK-1597 Absorption

Rapidly absorbed.

USAF EK-1597 side effects and Toxicity

Oral, rat LD50: 5628 mg/kg. Symptoms and effects of overdose include nausea, vomiting, CNS depression, acute respiratory failure or death and with chronic use, severe health problems, such as liver and brain damage.

USAF EK-1597 Patient Information

No information avaliable

USAF EK-1597 Organisms Affected

Humans and other mammals